WASHINGTON DC, USA -- PHARMA UPDATE NEWS SERVICE -- NOVEMBER 14, 2006: Failure to recruit subjects is the number one reason clinical trials do not meet deadlines. Compounded by failure to properly consent patients, 72 percent of all trials run over schedule by more than one month and only 6 percent are completed on time. Delayed or canceled studies and negative publicity can cost companies millions - even billions - of dollars.
With increased regulatory scrutiny and the growing complexity of clinical trials, your organization's success will depend upon its recruitment strategies and informed consent procedures. Discover how to speed the IRB and FDA review processes, shorten trial cycles and get your products to market faster.
In this two-day interactive workshop, Clinical Trials: Effective Recruitment and Informed Consent Strategies, you will:
- Explore the most recent guidelines for effective subject recruitment, and get proven tips on how you can meet FDA and OHRP expectations
- Learn practical, real-world approaches to incorporate HIPAA requirements into your informed consent documents
- Discover the top three reasons institutional review boards delay approval of studies - and help your organization prevent delays
- Analyze and prepare for the most common types of claims that occur when informed consent is not obtained
- Examine the five major reasons for subject participation in clinical trials
- Take home three strategies for implementing cost-saving recruitment techniques
- Improve your informed consent document writing skills, including eight recommendations for creating plain-language forms
- Participate in interactive practice exercises in effective and ineffective consenting procedures
- And much more!
MEET YOUR WORKSHOP LEADERS
The industry's foremost authorities on clinical trials hand you real-world solutions to shorten trial cycles and meet recruitment targets ahead of schedule - so your product can get to market.
100% SATISFACTION GUARANTEE
- Christine Pierre, RN, President and CEO, RxTrials, Inc.
- Mark Hochhauser, Ph.D., Consultant, Member of the Institutional Review Board, North Memorial Health Care
- Clint Hermes, Partner, Ropes & Gray LLP
- Linda Strause, Ph.D., Executive Director, Oncology Clinical Operations, Vical Inc.
Your satisfaction is 100% guaranteed - money back or credit. If you're not satisfied with the quality of this program, let us know in writing and we'll refund your registration fee or credit your tuition toward another FDAnews learning event.
WHO WILL BENEFIT:
- Executive Management
- Regulatory Affairs
- Legal and Compliance Officers
- Clinical Research Directors
- Clinical Investigators
- Clinical Research Coordinators
- Clinical Research Associates
- IRB Officials
- Project Managers
- Recruitment Specialists
- Strategic Planning and Business Development
Significant tuition discounts are available for teams of three or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount. Call +1 (703) 538-7600 for details.
Date: Dec. 11 - 12, 2006
TWO EASY WAYS TO REGISTER:
Hotel: Park Hyatt Philadelphia at the Bellevue
200 S. Broad St., Philadelphia, PA 19102
Toll free (800) 778-7477
Tel: +1 (215) 893-1234
Room rate: $210 single or double (plus 14% tax)
Hotel reservation cutoff date: Nov. 24, 2006
Tuition: $1,890 per attendee
Please use mention priority code 06NPML when registering.
- Enroll online
- Call toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600.